=== PAGE 35 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Important Safety Information (ISI) for
NEXTSTELLIS®

The following ISI is based on the highlights section of the US Prescribing Information for NEXTSTELLIS.
Please consult the full Prescribing Information for all labeled safety information for NEXTSTELLIS.

[A rectangular box with a dark border contains the following text:]
    WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS
        *See full prescribing information for complete boxed warning.*
    *   Females over 35 years old who smoke should not use NEXTSTELLIS.
    *   Cigarette smoking increases the risk of serious cardiovascular events from combination
        oral contraceptive (COC) use.
[End of boxed warning]

INDICATIONS AND USAGE
NEXTSTELLIS is a combination of drospirenone, a progestin, and estetrol, an estrogen,
indicated for use by females of reproductive potential to prevent pregnancy.

Limitations of Use
NEXTSTELLIS may be less effective in females with a BMI ≥30 kg/m². In females with
BMI ≥30 kg/m², decreasing effectiveness may be associated with increasing BMI.

34                                                [Image of "mayne pharma" logo: A black circle with "mayne pharma" written in white lowercase letters.]

                                                  Full Prescribing Information is available at www.Nextstellis.com
